News about Drug Discovery & Development

NATCO launches additional strengths for generic version of Revlimid in US

The generic version of Revlimid (lenalidomide capsules) are of strengths in 2.5 mg, and 20 mg

Drug Discovery & Development | 11/03/2023 | By Sudeep Soparkar |  1151

SK bioscience to Establish a Vaccine-Biopharma Hub

The R&PD center will be a 30,413.8 sq mt site in Songdo, Republic of Korea

Drug Discovery & Development | 13/02/2023 | By Sudeep Soparkar |  699

Mettler-Toledo Product Inspection to display wide range of pharma products at Interpack trade fair in May 2023

Under the banner theme of 'Boost Your Productivity' the Mettler-Toledo booth, A60 in Hall 11 at the Messe Düsseldorf, Germany, will comprise several different themed 'islands'

Drug Discovery & Development | 07/02/2023 | By Sudeep Soparkar |  649

Seqens opens flagship R&D centre in Greater Boston

The new facility will provide advanced capabilities for the discovery and development of new drugs and therapeutics
<br />

Drug Discovery & Development | 02/02/2023 | By Sudeep Soparkar |  1156

Aptar Pharma launches first metal-free nasal spray pump

Specifically designed for recyclability, APF Futurity is Aptar Pharma’s first highly recyclable nasal spray pump

Drug Discovery & Development | 31/01/2023 | By Sudeep Soparkar |  1187

Sun Pharma Launches SEZABY in US to treat neonatal seizures

This is the first and only FDA Approved product in US to treat neonatal seizures

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar |  1159

ENTOD Pharma's state-of-the-art R&D facility opens in Navi Mumbai

The brand new additional R&D facility in Navi Mumbai has been designed with state-of-the-art equipment and the latest analytical & formulation research tools

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar |  954

Marksans Pharma announces UK MHRA approval for Fluoxetine 20mg/5ml oral solution

The product will be manufactured at the plant of Bell, Sons & Co, UK

Drug Discovery & Development | 24/01/2023 | By Sudeep Soparkar |  623

Eurofins CDMO Alphora expands API development labs

The 56,000-square foot building is the new home of Eurofins CDMO Alphora’s API process R&D activity, solid-state R&D activity and its analytical services team

Drug Discovery & Development | 17/01/2023 | By Sudeep Soparkar |  871

AstraZeneca partners with Australia-based LBT Innovations for new pharma product line

AstraZeneca will fund the development of the APAS Pharma analysis module and validate the final product for their processes
<br />

Drug Discovery & Development | 12/01/2023 | By Sudeep Soparkar |  750